Dr. Bhupesh Parashar, MD

Dr. Parashar practices at Northwell Health Physician Partners Cardiology in New Hyde Park, New York.

Dr. Parashar's NPI, 1073627287, was assigned on August 18, 2006. Dr. Parashar holds New York license 236379.

Dr. Parashar's primary practice is Northwell Health Physician Partners Cardiology, at 450 Lakeville Rd, New Hyde Park, NY 11042 in Nassau County. The practice phone is (516) 321-7400.

Dr. Parashar's primary practice is Northwell Health Physician Partners Cardiology in New Hyde Park, New York. Dr. Parashar is also affiliated with Long Island Jewish Medical Center. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Parashar to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parashar practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Parashar's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Parashar is licensed in New York.

CMS data shows 1,509 Medicare services from Dr. Parashar across 15 procedure codes in 2024, for 138 Medicare patients. Medicare paid $294,353 for them. Every service was in an office.

CMS counts 138 Medicare patients who saw Dr. Parashar in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have cancer, and 75% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Parashar's median patient age at 74, with 43% women.

In 2024, Dr. Parashar wrote 48 Medicare Part D claims for 22 patients. 98% of them were for generic drugs. CMS names the drug for 31 of them, across 1 drug with 11 or more claims each, at $217 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Parashar for performance year 2024, reported through an alternative payment model (APM). Dr. Parashar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Parashar as offering telehealth.

Dmand AI links 83 papers to Dr. Parashar, published from 2009 to 2025. 2019 was the busiest year, with 6. The most frequent topics are Brachytherapy, Radiotherapy, Adjuvant and Lung Neoplasms. Dr. Parashar has published most often in Cureus. Dr. Parashar's most frequent co-authors are Louis Potters, MD, Theodore H. Schwartz, MD and Susan C. Pannullo, MD.

Dmand AI links Dr. Parashar to 3 clinical trials. Conditions studied include Carcinoma, Non-Small-Cell Lung, Lung Neoplasms and Stomatitis.

CMS Open Payments shows 9 general payments to Dr. Parashar from 5 drug and device companies from 2016 to 2022. Consulting fees make up the largest share, 80% of the total. Novocure Inc. paid the most, $1,805.